Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Amgen
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 6 ans
Étude 20160275 : étude de phase 3 randomisée visant à comparer l’efficacité de l’association carfilzomib, dexaméthasone et daratumumab avec celle de l’association carfilzomib et dexaméthasone chez des patients ayant un myélome multiple récurrent ou réfractaire.
Le myélome multiple est une maladie maligne touchant les plasmocytes de la moelle osseuse, qui font partie des globules blancs assurant la défense contre les infections. Si un type malin de plasmocyte...
Country
France
organs
Myélomes
Specialty
Immunothérapie - Vaccinothérapie
,
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Study to assess the long term safety and efficacy of AMG 145 in patients with high concentrations of lipids in the blood
To characterize the safety and tolerability of long-term administration of AMG 145
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A study to find out more about the effect of AMG 181 in people with moderate to severe Crohn's Disease
To evaluate the efficacy of AMG 181 as measured by the proportion of subjects achieving Crohn’s Disease Activity Index (CDAI) remission (CDAI < 150) at week 8
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Study to determine the adequate dose of a new medicine omecantiv mecarbil compared to placebo in patients with a heart condition whereby the ability of the heart to pump enough blood to meet the body’s need at all times is reduced
(i) to select an oral modified release (MR) formulation and dose of omecamtiv mecarbil for chronic twice daily (BID) dosing in subjects with HF and left ventricular systolic dysfunction and (ii) to c...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A study investigating the use of Omecamtiv Mecarbil on subjects with heart failure
To evaluate the effect of treatment with omecamtiv mecarbil compared with placebo on the time to cardiovascular (CV) death or first HF event, whichever occurs first, in subjects with chronic HF with r...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Randomized, Double-Blind, Placebo Controlled, Multiple Dose Phase 2 Study to Determine the Safety and Efficacy of AMG 853 in Subjects with Inadequately Controlled Asthma
The primary objective is to determine if AMG 853 is effective compared with placebo as measured by change in Asthma Control Questionnaire (ACQ) symptom scores from baseline to week 12.
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Amgen (UK)
Update Il y a 4 ans
High Dose Therapy in Poor-Risk Primary Breast Cancer
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Global, Multicenter, Open-label, Single Agent, Two-stage Phase 2 Study to Evaluate the Efficacy and Safety of AMG 102 in Subjects With Advanced Renal Cell Carcinoma
To assess objective response rate in subjects with advanced renal cell carcinoma receiving AMG 102 treatment.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
Amgen 20050201 : Essai de phase 3 randomisé, en double aveugle, comparant l’efficacité d'un traitement par AMG706 associé au paclitaxel et au carboplatine chez des patients ayant un cancer du poumon. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de l’essai est d'évaluer l’apport de AMG706 associé à une chimiothérapie par palitaxel et par carboplatine chez des patients ayant un cancer du poumon. Les patients seront répartis de faço...
Country
France
organs
Poumon, type non à petites cellules
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Study designed to evaluate the safety and efficacy of Evolocumab compared with placebo, in people with diabetes who have high cholesterol and who are already taking statin treatment
To evaluate the effect of 12 weeks of subcutaneous (SC) evolocumab every 2 weeks (Q2W) and monthly (QM), in combination with oral (PO) atorvastatin daily (QD), compared with placebo Q2W and QM, in com...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
12
13
14
15
16
17
18
19
20
21
Next